Another Disappointing Year for Alzheimer’s Drugs

It’s been rough times for the development of Alzheimer’s drugs.

Last month, Myriad Genetics said its late-stage trial of its experimental drug Flurizan failed to show any benefit for Alzheimer’s patients. Another late-stage study, of Alzhemed from Canada’s Neurochem, failed last fall.

The results of the Flurizan study will be unpacked this week at a big annual Alzheimer’s conference, as researchers look at what’s next in the field, the Los Angeles Times reports this morning. Read More >>

Post a purple ribbon and support the cause!

In honor of my grandparents Betty and Elmer Is it Alzheimer's? Get a Web Ribbon

We are pleased to announce a new alliance with Caring.com and have teamed up to create a purple ribbon Web widget to help increase awareness about Alzheimer's and raise money for the cause. The ribbon can be posted to any Web site or blog and personalized. For every purple ribbon posted, Caring.com will contribute $10 (up to $10,000) to the Alzheimer's Association to support research and care programs! We hope you have fun creating and customizing your purple ribbon and, once again, thank you for helping to advance our mission.